TNX-4300’s Mechanism of Restoring Neuroplasticity Supports Development as a First-in-Class Oral Therapy for Depression, Bipolar Disorder, Alzheimer’s Disease and Parkinson’s Disease
Microbion Corp. Granted US Patent for the Use of Inhaled Pravibismane for Pulmonary Infections
Extends patent protection for Microbion’s proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039.
UM Researcher Uses AI to Understand Lung Cancer Cell Vulnerabilities
A scientific team that includes University of Montana biologist Mark Grimes recently used artificial intelligence to better understand how protein groups in lung cancer cells regulate cell division and metabolism. The work may lead to greater understanding of lung cancer vulnerabilities and future anti-cancer therapies.
Nelson Labs Bozeman Announces GMP Viral Clearance Testing Service
Viral clearance testing is a critical step in the development and production of biologics and other products that are derived from biological sources. GMP-compliant service provides the assurance that products have been thoroughly tested for the presence of viral contaminants, and that they are safe for use.
Join the HERO Patients Registry
Scientists at the McLaughlin Institute are spearheading this patient registry which allows the Institute to enroll Montanans in potential clinical trials and research studies.
Three Tips for Scaling Biotech Companies in Montana
On January 12, 2023, the Montana High Tech Business Alliance and the Montana Bioscience Cluster Initiative co-hosted the webinar “Scaling Biotech Companies in Montana.” Panelists shared their insights into how companies can effectively plan for growth and how Montana can scale its biotech ecosystem.
UM Earns Research Award for Submicroscopic 3D Printer
A University of Montana research center recently was awarded a $480,000 grant to support the purchase of a three-dimensional bioprinter, which will allow nanofabrication of tiny structures.
UM Public Health Students Earn Award to Study Major Issues in Montana
Five UM public health master’s students working on projects that tackle some of the largest health issues facing the state and region recently earned the regional Student Leaders in Public Health Award from the Rocky Mountain Public Health Training Center in the Colorado School of Public Health. The award provides $3,500 to each project.
Microbion Corporation Initiates Phase 2 Clinical Study Evaluating Topical Pravibismane Treatment of Diabetic Foot Infections
Microbion Corporation today announced that a Phase 2, randomized, controlled study has been initiated to assess the safety and efficacy of topical pravibismane for the treatment of subjects with moderate infections of chronic diabetic foot ulcers (DFU).